Open an account

Alcon AG

ALC · SWISS

$70.17−$0.46 (−0.65%)TodayMarket closed ·
Prev close $70.63

About ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,942 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.

Employees
25,942
Headquarters
Fribourg, Fribourg
Listed
Apr 9, 2019
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
alcon.ch

ALC key statistics

Market cap
28.90B
Price-earnings ratio
53.51
Dividend yield
0.51%
Average volume
1.74M
Volume
2.59M
Open price
$70.16
High today
$70.46
Low today
$69.54
52 Week high
$87.64
52 Week low
$61.84

Alcon AG (ALC) at a glance

As of Oct 23, 2026, Alcon AG (ALC) shares are priced at $70.17, giving the company a market cap of 28.90B, a price-to-earnings ratio of 53.51 and a dividend yield of 0.51%.

Today the stock has traded between $69.54 and $70.46. The current price is 0.9% above the day's low and 0.4% below its high.

Volume so far is 2.59M shares, above the average of 1.74M shares a day.

Over the past year Alcon AG has ranged from $61.84 to $87.64, and now sits 32% of the way up that range.

Alcon AG met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.84 per share against an estimate of $0.7601.

The average analyst price target is $93.44, 33.2% above the current price, from 10 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 10 analyst ratings say Buy
  • Buy50.0%
  • Hold40.0%
  • Sell10.0%
Price target · 16 analystsAvg $93.44
Low
$58.46
Now
$70.17
High
$124.08

ALC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 4.9% on average.

  1. Q3 FY24: reported $0.81 per share against an estimate of $0.7522
  2. Q4 FY24: reported $0.72 per share against an estimate of $0.7159
  3. Q1 FY25: reported $0.73 per share against an estimate of $0.7625
  4. Q2 FY25: reported $0.76 per share against an estimate of $0.7274
  5. Q3 FY25: reported $0.79 per share against an estimate of $0.7678
  6. Q4 FY25: reported $0.78 per share against an estimate of $0.7925
  7. Q1 FY26: reported $0.85 per share against an estimate of $0.822
  8. Q2 FY26: reported $0.84 per share against an estimate of $0.7601

ALC news

  • Press releaseBusiness Wire

    Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2

  • Press releaseBusiness Wire

    FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes

  • Press releaseBusiness Wire

    Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief

  • Press releaseBusiness Wire

    Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control

  • Namrata Sen

    Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President

  • Press releaseBusiness Wire

    Alcon Prices EUR 500 Million Senior Notes Offering

  • Kaustubh Bagalkote

    Why Is Netflix Stock Falling on Monday?

  • Chandrima Sanyal

    Bill Ackman’s New Stock Picks Are Here. These ETFs Could Be Worth Watching

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.